Israel excels in melanoma treatment, with leading centers like Sourasky Medical Center (Ichilov), Hadassah, and Assuta Medical Center. Sourasky reports a 90% success rate in oncology. Hadassah serves over 1,000,000 patients yearly. Assuta Medical Center, accredited by the Joint Commission International, offers patient-centered care, allowing choice in treatment and medical teams.
Innovative treatments include targeted therapy, immunotherapy, Mohs surgery, and oncolytic virus therapy. Israel's healthcare sy, supported by research, contributes to high success in melanoma treatment. The five-year survival for melanoma in Israel is between 88.1% and 89.4%.